CHRISTY ODONNELL: Open Payments
NPI 1831202183 · STAMFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 26 payments from 8 companies in 2025. Trend: 2023 $313 · 2024 $472 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| ABBVIE INC. | 6 | $122 |
| PFIZER INC. | 4 | $114 |
| Lilly USA, LLC | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Novo Nordisk Inc | 2 | $32 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, ELIQUIS, BREZTRI, MOUNJARO, AIRSUPRA, REXULTI, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
